Innova Captab Limited · NSE:INNOVACAP
Innova Captab — Q3 FY26 Earnings Presentation
27 slides from Innova Captab's earnings presentation, Jan 23, 2026
Slide 1: Intimation of Investor Presentation to Stock Exchanges
INNOVA CAPTAB LIMITED Plot No. 320, Industrial Area, Phase-1, Panchkula, Pin-134113, Haryana, India. Phone: +91-172-4194500 23rd January, 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block
Slide 2: Excelling with Passion, Powering Potential
Excelling with Passion Powering Potential Investor Presentation - 23rd January 2026
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Innova Captab Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securit
Slide 4: Company Overview
Company Overview
Slide 5: Leading Pharmaceutical Player with Comprehensive Business Model
Leading Pharmaceutical Player with Comprehensive Business Model Robust Financials Preferred CDMO partner for prominent pharmaceutical companies worldwide, with a strong direct (FY25) presence across geographies through our branded generics business Revenues ₹ 1,244 Cr EBITDA 300 + Presence across 60
Slide 6: With State-of-the-Art Manufacturing Facilities
With State-of-the-Art Manufacturing Facilities Key Accreditations 9 Manufacturing Blocks Kathua, Jammu [4 Blocks] 3 Baddi |1 Dehradun |1 Taloja | 4 Jammu Upcoming R&D Baddi, Himachal Pradesh (2 Units) [3 Blocks] Facility in R&D Facility in Baddi, Himachal Pradesh Panchkula, Haryana Dehradun, Uttarak
Slide 7: Journey of Achieving Major Milestones
Journey of Achieving Major Milestones Acquisition of Sharon • Innova Captab began its • Received GMP Certificate for • Acquisition of Sharon, through the journey in 2006 with the cephalosporin products from • Further expanded the G block Corporate Insolvency Resolution Process establishment of first
Slide 8: Q3 & 9M FY26 Performance Highlights
Q3 & 9M FY26 Performance Highlights
Slide 9: MD's Commentary
MD’s Commentary Innova Captab Ltd delivered accelerated YoY revenue growth of 42% in Q3 FY26 and of 27% in 9M FY26. This strong performance underscores disciplined execution across our operations. This growth reflects improved client engagement in CDMO business and strategic geographic expansion in
Slide 10: Q3 & 9MFY26 Performance Highlights - Revenue
Q3 & 9MFY26 Performance Highlights - Revenue Revenue (₹ Crore) +27% • Revenue from Operations registered stellar YoY growth of 42% in Q3 1182.2 and of 27% in 9M FY26 • This was driven by growth across all facets – improved client 928.9 +42% engagement, enhanced product offerings and expanded geograp
Slide 11: Q3 & 9MFY26 Performance Highlights - Profitability
Q3 & 9MFY26 Performance Highlights - Profitability EBITDA (₹ crore) Margin 16.1% 15.8% 15.8% 15.5% +25% 183.7 • EBITDA for Q3 FY26 stood at ₹ 71.1 crores reflecting a robust YoY 147.1 +40% growth of 40%. For 9M FY26, EBITDA was ₹ 183.7 crores growing 25% vs ₹ 147.1 crores in 9M FY25 71.1 50.9 • EBIT
Slide 12: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Profit and Loss (₹ crore) Q3 FY26 Q3 FY25 YoY Growth 9M FY26 9M FY25 YoY Growth Revenue from Operations 450.3 316.5 42.3% 1182.2 928.9 27.3% Other Income 1.6 4.3 5.9 8.7 Total Income 451.9 320.8 40.9% 1188.1 937.6 26.7% Cost of Material Consumed 291.8 209.9 756.1
Slide 13: Key Strengths
Key Strengths
Slide 14: Building on Core Strengths, Unlocking Future Growth
Building on Core Strengths, Unlocking Future Growth Extensive Product Offerings, Wider Reach, R&D Centric Organization Stronger Future Comprehensive Business Experienced Promoters and Model Board of Directors Relentless Expansion of Consistent Financial Manufacturing Capabilities: Performance Fuel f
Slide 15: Relentless Expansion of Manufacturing Capabilities (1/3)
Relentless Expansion of Manufacturing Capabilities: Fuel for Sustained Growth (1/3) Our manufacturing Capabilities Jammu Plant Dehradun & Taloja Plant Baddi Plant Expansion through New Greenfield Project Expansion through Inorganic 2025 onwards Acquisition Building blocks for growth 2024 Tablets Cap
Slide 16: Capacity Expansion in Jammu (2/3)
Capacity Expansion in Jammu (2/3) Eligible for following benefits via Central Government's 'New Central Sector Scheme ₹ 480+ crore GST-linked incentive totaling to 300% of investment made in Capital Interest Subvention of 6% per Total Capital Investment eligible plant and machinery annum on loan aga
Slide 17: Growth led by Capacity Expansion (3/3)
Growth led by Capacity Expansion (3/3) Baddi Plant Dehradun & Taloja Plant Jammu Plant 15% - 20% 15% - 20% 20%-30% 70% - 75% 40%-50% 70%-75% 70% - 75% 50% - 55% 50% - 60% FY25 Un-utilized Capacity Optimum Utilization FY25 Un-utilized Capacity Optimum Utilization Commenced Ramp up in Further Optimum
Slide 18: Comprehensive Business Model
Comprehensive Business Model CDMO Services and Products 3,700 + Products • Preferred partner for companies seeking to efficiently deliver high-quality, affordable medicines to market. • Consistently deliver high-quality solutions at scale, while maintaining the 300 + flexibility to tailor offerings
Slide 19: Extensive Product Offerings, Wider Reach, Stronger Future
Extensive Product Offerings, Wider Reach, Stronger Future FY21 FY25 Ongoing development of various formulations will drive Number of Products 1,000 + 3,700 + continued growth in product offerings 119 300+ Focus on consistently adding new clients, with sustained efforts to effectively service the exi
Slide 20: R&D Focused Organisation + R&D Laboratory
R&D Focused Organisation 40 + R&D Laboratory Scientist & Engineers Baddi, Himachal Pradesh Robust Research and Development • Dedicated R&D facility and pilot equipment located in Baddi, Himachal Pradesh, recognized by the DSIR for its in-house R&D work • State-of-the-art facility equipped with a com
Slide 21: Experienced Promoters and Board of Directors
Experienced Promoters and Board of Directors Mr. Manoj Kumar Lohariwala Mr. Vinay Lohariwala Mr. Jayant Vasudeo Rao Mr. Archit Aggarwal Chairman and Whole-Time Director Managing Director Whole-Time Director Non-Executive Non-Independent Director Mr. Sudhir Kumar Bassi Ms. Priyanka Dixit Sibal Mr. Ma
Slide 22: Consistent Financial Performance
Consistent Financial Performance Revenue from Operations EBITDA (₹ crore) PAT (₹ crore) (₹ crore) 13.6% 12.4% 13.3% 15.4% 15.9% 8.4% 8.0% 7.3% 8.7% 10.3% Margin +32% 1,244 1,081 198 926 +37% 167 801 128 +38% 123 99 94 411 64 68 56 35 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 F
Slide 23: Historical Financial Performance
Historical Financial Performance
Slide 24: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Profit and Loss (₹ crore) FY25 FY24 FY23 FY22 FY21 Revenue from Operations 1,243.7 1,081.3 926.4 800.5 410.7 Other Income 12.0 12.5 9.2 2.9 1.4 Total Revenue 1,255.7 1,093.8 935.6 803.4 412.0 Cost of Materials Consumed 814.1 728.3 691.6 617.9 310.7 Employee Cost
Slide 25: Consolidated Balance Sheet
Consolidated Balance Sheet Assets (₹ crore) FY25 FY24 FY23 FY22 FY21 Equity & Liabilities (₹ crore) FY25 FY24 FY23 FY22 FY21 Non - Current Assets 877.3 741.1 261.9 196.4 99.1 Total Equity 959.4 830.9 276.5 208.6 144.8 Property, plant and equipment 766.9 291.6 150.1 156.6 76.4 Share Capital 57.2 57.2
Slide 26: Consolidated Cash Flow
Consolidated Cash Flow Particulars (₹ crore) FY25 FY24 FY23 FY22 FY21 Net Profit Before Tax 171.0 129.5 91.8 85.7 46.3 Adjustments for: Non -Cash Items / Other Investment or Financial Items 31.3 37.2 25.9 15.3 9.6 Operating profit before working capital changes 202.3 166.7 117.7 101.0 55.9 Changes i
Slide 27: Thank You!
Thank You! Innova Captab Limited : Investor Relations Advisor : http://www.sgapl.net/images/sgapl_logo.jpg Strategic Growth Advisors Pvt. Ltd. Innova Captab Ltd. CIN - U74140MH2010PTC204285 CIN – L24246MH2005PLC150371 Ms. Shaily Patwa / Mr. Shrikant Sangani Mr. Lokesh Bhasin/ Mr. Ayush Kumar Garg Em